As broader approval for GLP-1 weight loss drugs spurs higher demand, it’s also causing employer drug spending to spike.

Additionally, looking towards next week, industry players such as Kinder Morgan ( NYSE: KMI) and Morgan Stanley (NYSE: MS) will see the ex-dividend dates for their upcoming dividend payments. See a ...